Mona M. Elwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mona M. Elwan has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Eman E. El-Nahass
Zoology department, faulty of sciene, tanta university, tanta, egypt
3 shared publicationsBasant I. Salem
Tanta University Faculty of Science
1 shared publicationEhab O. Elshennawy
Zoology department, faculty of science , tanta university, tanta, egypt
1 shared publication- Ehab Othman Elshennawy
Tanta University, Egypt
1 shared publication Eman El Sayed Mohammed El Nahass
1 shared publicationFatehyia Makboul
1 shared publication
Latest Publications
- Open Access
- 1 February 2024
- Published by Egyptian Knowledge Bank in Biological and Biomedical Journal
- Vol. 2 (1) , 56-66
Optimizing the antitumor efficacy of cisplatin low doses by the co-treatment with ethylenediamine tetra acetic acid in EAC-bearing mice
Cancer disease remains one of the most cause of death worldwide. Thedrawbacks that were associated to the chemotherapy treatments are impetusfor finding more efficacious, and better tolerated new drugs. This study wasconducted to optimize the low doses of cisplatin (Cis) antitumor effect by theco-treatment of ethylenediamine tetra acetic acid (EDTA) in EAC-bearingmice. Sixty-four female CD-1 mice were divided into eight groups (n = 8) asfollows: Gp1 was a negative control. Gp2 had inoculated with 1×106 EACcells/mouse interperitoneally (i.p.). Gp3, Gp4 and Gp5 had inoculated withthe same number of EAC-cells as in Gp2, then injected with 0.125, 0.250 or0.5 mg/Kg of Cis i.p, respectively. Gp6, Gp7 and Gp8 had inoculated withEAC-cells as in Gp2, then injected with the low doses of Cis as in Gp3- G5in combination with EDTA (50 mg/Kg), respectively. At day 14, all groupswere bled to collect sera for biochemical assessments. The tumor ascites wascollected for determining the total tumor volume and total tumor counts.Liver tissues were harvested for histopathological investigations. The resultsshowed that co-treatment of EDTA (50 mg/Kg) along with the low doses ofCis (0.125, 0.25 or 50 mg/Kg) led to significant reduction in tumor volume,tumor cells count, improved the liver, kidney functions, and antioxidantstatus. Among all the treated EAC-bearing mice groups, mice that had acombined treatment with Cis (0.5 mg/Kg) and EDTA (50 mg/Kg) showedthe highest antitumor effect with highly improvements in the liver functionsand architectures.
- 1 February 2024
- Published by Egyptian Knowledge Bank in Biological and Biomedical Journal
- Vol. 2 (1) , 56-66
Open AccessOptimizing the antitumor efficacy of cisplatin low doses by the co-treatment with ethylenediamine tetra acetic acid in EAC-bearing mice
Cancer disease remains one of the most cause of death worldwide. Thedrawbacks that were associated to the chemotherapy treatments are impetusfor finding more efficacious, and better tolerated new drugs. This study wasconducted to optimize the low doses of cisplatin (Cis) antitumor effect by theco-treatment of ethylenediamine tetra acetic acid (EDTA) in EAC-bearingmice. Sixty-four female CD-1 mice were divided into eight groups (n = 8) asfollows: Gp1 was a negative control. Gp2 had inoculated with 1×106 EACcells/mouse interperitoneally (i.p.). Gp3, Gp4 and Gp5 had inoculated withthe same number of EAC-cells as in Gp2, then injected with 0.125, 0.250 or0.5 mg/Kg of Cis i.p, respectively. Gp6, Gp7 and Gp8 had inoculated withEAC-cells as in Gp2, then injected with the low doses of Cis as in Gp3- G5in combination with EDTA (50 mg/Kg), respectively. At day 14, all groupswere bled to collect sera for biochemical assessments. The tumor ascites wascollected for determining the total tumor volume and total tumor counts.Liver tissues were harvested for histopathological investigations. The resultsshowed that co-treatment of EDTA (50 mg/Kg) along with the low doses ofCis (0.125, 0.25 or 50 mg/Kg) led to significant reduction in tumor volume,tumor cells count, improved the liver, kidney functions, and antioxidantstatus. Among all the treated EAC-bearing mice groups, mice that had acombined treatment with Cis (0.5 mg/Kg) and EDTA (50 mg/Kg) showedthe highest antitumor effect with highly improvements in the liver functionsand architectures.
- 1 March 2022
- Published by Egyptian Knowledge Bank in International Journal of Cancer and Biomedical Research
- Vol. 6 (1) , 77-87
Metformin treatment improves the hepato-renal dysfunctions induced in Type-II diabetes in male rats
Background: Metformin is one of the alternative drugs to treat Diabetic mellitus type 2 (T2DM). One of the chronic symptoms of T2DM is the dysfunctionality of some vital organs. Aim: This study evaluates the role of metformin treatment to improve the liver and kidney functions of T2DM rats. Material and Methods: Forty rats were divided into four groups (n=10) as follows: group 1 (Gp1) was orally administered with 200 µl of distilled water. Gp2 was administered with metformin (200 mg/Kg) daily for two months. Gp3 and 4 were fed on high fat diet for 5 weeks, then Gp3 was injected with streptozotocin (STZ) (40 mg/Kg) once intraperitoneal (i.p.). Gp4 was injected with STZ as in Gp3 then administered with metformin as in Gp2. All rats were sacrificed to analyze the hematological, biochemical, and histopathological changes. Results: Metformin administration decreased the total body weight of both naïve and T2DM rats. Furthermore, metformin improves hepato-renal dysfunctions induced in T2DM rats as evidenced by decreasing the levels of ALT, AST, urea, and creatinine. The level of malondialdehyde was decreased while superoxide dismutase, catalase, and reduced glutathione levels were increased in the group of T2DM rats that were administrated with metformin. Treatment of T2DM rats with metformin increased C-Peptide and decreased glycose levels. Furthermore, histopathological investigations showed an improvement in the liver and kidney tissues upon treatment of T2DM rats with metformin. Conclusion: The treatment of T2DM rats with metformin for long period improves hepato-renal dysfunctions.
- 1 March 2022
- Published by Egyptian Knowledge Bank in International Journal of Cancer and Biomedical Research
- Vol. 6 (1) , 77-87
Metformin treatment improves the hepato-renal dysfunctions induced in Type-II diabetes in male rats
Background: Metformin is one of the alternative drugs to treat Diabetic mellitus type 2 (T2DM). One of the chronic symptoms of T2DM is the dysfunctionality of some vital organs. Aim: This study evaluates the role of metformin treatment to improve the liver and kidney functions of T2DM rats. Material and Methods: Forty rats were divided into four groups (n=10) as follows: group 1 (Gp1) was orally administered with 200 µl of distilled water. Gp2 was administered with metformin (200 mg/Kg) daily for two months. Gp3 and 4 were fed on high fat diet for 5 weeks, then Gp3 was injected with streptozotocin (STZ) (40 mg/Kg) once intraperitoneal (i.p.). Gp4 was injected with STZ as in Gp3 then administered with metformin as in Gp2. All rats were sacrificed to analyze the hematological, biochemical, and histopathological changes. Results: Metformin administration decreased the total body weight of both naïve and T2DM rats. Furthermore, metformin improves hepato-renal dysfunctions induced in T2DM rats as evidenced by decreasing the levels of ALT, AST, urea, and creatinine. The level of malondialdehyde was decreased while superoxide dismutase, catalase, and reduced glutathione levels were increased in the group of T2DM rats that were administrated with metformin. Treatment of T2DM rats with metformin increased C-Peptide and decreased glycose levels. Furthermore, histopathological investigations showed an improvement in the liver and kidney tissues upon treatment of T2DM rats with metformin. Conclusion: The treatment of T2DM rats with metformin for long period improves hepato-renal dysfunctions.
- Open Access
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 7990129
Prevention of Hepatorenal Insufficiency Associated with Lead Exposure by Hibiscus sabdariffa L. Beverages Using In Vivo Assay
Lead pollution is a major environmental challenge worldwide. Therefore, dietary interventions that are aimed at preventing lead’s deleterious effects on body organs are needed. The study’s goal was to study and compare the protective effect of cold and hot beverages of Roselle (Hibiscus sabdariffa L.) red calyces (CRB and HRB, respectively) on liver and kidney insufficiency associated with lead exposure in male rats. Adult albino rats (32 males) were divided into four groups of equal number, including a normal control (group 1), while groups from 2 to 4 received lead acetate (20 mg/kg body weight/day) and were kept untreated (group 2). The 3rd and the 4th groups received CRB and HRB (0.5 ml/100 g body weight/day), respectively, for 6 weeks. The gain in the body and relative weights of the liver and kidneys were calculated. Liver and kidney functions were determined in serum, while lead, delta‐aminolevulinic acid dehydratase, and oxidative stress markers were established in tissues. Specimens from the liver and kidney of sacrificed rats were histopathologically examined. The total activity of antioxidants and total content of anthocyanin of both beverages were determined. Lead exposure resulted in its accumulation in tissues, leading to overweight and liver and kidney insufficiency along with oxidative stress, which was further confirmed by histological staining. CRB was more efficient than HRB in preventing the deleterious effects of lead intoxication. Due to their antioxidant properties, the present study proved that Roselle red calyx beverages, particularly the cold ones, are protective agents against lead‐associated disorders in a rat model.
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 7990129
Open AccessPrevention of Hepatorenal Insufficiency Associated with Lead Exposure by Hibiscus sabdariffa L. Beverages Using In Vivo Assay
Lead pollution is a major environmental challenge worldwide. Therefore, dietary interventions that are aimed at preventing lead’s deleterious effects on body organs are needed. The study’s goal was to study and compare the protective effect of cold and hot beverages of Roselle (Hibiscus sabdariffa L.) red calyces (CRB and HRB, respectively) on liver and kidney insufficiency associated with lead exposure in male rats. Adult albino rats (32 males) were divided into four groups of equal number, including a normal control (group 1), while groups from 2 to 4 received lead acetate (20 mg/kg body weight/day) and were kept untreated (group 2). The 3rd and the 4th groups received CRB and HRB (0.5 ml/100 g body weight/day), respectively, for 6 weeks. The gain in the body and relative weights of the liver and kidneys were calculated. Liver and kidney functions were determined in serum, while lead, delta‐aminolevulinic acid dehydratase, and oxidative stress markers were established in tissues. Specimens from the liver and kidney of sacrificed rats were histopathologically examined. The total activity of antioxidants and total content of anthocyanin of both beverages were determined. Lead exposure resulted in its accumulation in tissues, leading to overweight and liver and kidney insufficiency along with oxidative stress, which was further confirmed by histological staining. CRB was more efficient than HRB in preventing the deleterious effects of lead intoxication. Due to their antioxidant properties, the present study proved that Roselle red calyx beverages, particularly the cold ones, are protective agents against lead‐associated disorders in a rat model.
- Open Access
- 1 October 2021
- Published by Springer Nature in Research Square
Evaluation the toxic effects of Cobalt/Zinc/Ferrite nano-complex in experimental mice
Currently, nanoparticles (NPs) are in use in several applications especially in the biomedical field. The NPs showed promising results in the treatment of several diseases, however, NP S could have toxic effects on some vital organs. This study was conducted to evaluate the possible toxicity of Cobalt/Ferrite (CF NPs) and Cobalt/Zinc/Ferrite (CZF NPs) nano-complex. Eighty female mice were used to determine the median lethal dose (LD 50 ) of CF NPs (100 mg/kg) and CZF NPs (100 mg/kg). Thirty female mice CD1 were divided into 3 groups (n=10) as follows: Group 1 (Gp1). Mice were injected with 200 µl of sterile saline interperitoneal (i.p.). Gp2 and Gp3 were injected with CF NPs and CFZ NPs for 6 days. Hematological, biochemical, and histopathological parameters were determined at day 14 post injection. The results showed that there was a significant change in the total body weight in CZF NPs injected mice. CF NPs injections did not alter the values of the total red blood cells (RBCs), haemoglobin conc (Hb), hematocrit Hct%, total white blood cells (WBCs) and platelets while CZF NPs injections increased WBCs count and decrease the platelets count. Also, injection of CZF NPs altered the differential leukocyte percentages. There was no significant change in liver and kidney functions in CF NPs injected mice, while CZF NPs exhibited significant increases in liver and kidney bio-markers. The injection of mice with CF NP S didn´t alters the histological architecture of hepatic and renal tissues, while the hepatic and renal structures were disorganized in CZF NPs injected mice. Collectively, the results revealed that CZF NPs showed a degree of toxicity on experimental mice.
- 1 October 2021
- Published by Springer Nature in Research Square
Open AccessEvaluation the toxic effects of Cobalt/Zinc/Ferrite nano-complex in experimental mice
Currently, nanoparticles (NPs) are in use in several applications especially in the biomedical field. The NPs showed promising results in the treatment of several diseases, however, NP S could have toxic effects on some vital organs. This study was conducted to evaluate the possible toxicity of Cobalt/Ferrite (CF NPs) and Cobalt/Zinc/Ferrite (CZF NPs) nano-complex. Eighty female mice were used to determine the median lethal dose (LD 50 ) of CF NPs (100 mg/kg) and CZF NPs (100 mg/kg). Thirty female mice CD1 were divided into 3 groups (n=10) as follows: Group 1 (Gp1). Mice were injected with 200 µl of sterile saline interperitoneal (i.p.). Gp2 and Gp3 were injected with CF NPs and CFZ NPs for 6 days. Hematological, biochemical, and histopathological parameters were determined at day 14 post injection. The results showed that there was a significant change in the total body weight in CZF NPs injected mice. CF NPs injections did not alter the values of the total red blood cells (RBCs), haemoglobin conc (Hb), hematocrit Hct%, total white blood cells (WBCs) and platelets while CZF NPs injections increased WBCs count and decrease the platelets count. Also, injection of CZF NPs altered the differential leukocyte percentages. There was no significant change in liver and kidney functions in CF NPs injected mice, while CZF NPs exhibited significant increases in liver and kidney bio-markers. The injection of mice with CF NP S didn´t alters the histological architecture of hepatic and renal tissues, while the hepatic and renal structures were disorganized in CZF NPs injected mice. Collectively, the results revealed that CZF NPs showed a degree of toxicity on experimental mice.
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 64
Metformin Causes Hepato-renal Dysfunctions in Obese Male Rats
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 64
Open AccessMetformin Causes Hepato-renal Dysfunctions in Obese Male Rats
- Open Access
- 1 January 2019
- Published by Herbert Publications PVT LTD in Journal of Histology and Histopathology
- Vol. 6 (1) , 3
Comparitive histological and ultrastructural studies on the stomach of African cat fish (Clarias gariepinus) and (Oreochromis niloticus)
This study aims to illustrate the morphological, histological and ultrastructural differences in the stomach of a carnivorous fish, Clarias gariepinus and an herbivorous fish Oreochromis niloticus in
- 1 January 2019
- Published by Herbert Publications PVT LTD in Journal of Histology and Histopathology
- Vol. 6 (1) , 3
Open AccessComparitive histological and ultrastructural studies on the stomach of African cat fish (Clarias gariepinus) and (Oreochromis niloticus)
This study aims to illustrate the morphological, histological and ultrastructural differences in the stomach of a carnivorous fish, Clarias gariepinus and an herbivorous fish Oreochromis niloticus in